Search results
BioNTech SE (NASDAQ:BNTX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Simply Wall St. via Yahoo Finance· 8 hours agoInvestors in BioNTech SE (NASDAQ:BNTX) had a good week, as its shares rose 2.3% to close at US$90.88...
BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoBioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript May 6, 2024 BioNTech SE isn’t one of the...
BioNTech reports net loss of €315.1m in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 1 day agoBioNTech has experienced a significant shift in its financial standing, reporting a net loss of €315.1m ($339.3m) in the first quarter (Q1) of 2024. This...
BioNTech Target of Unusually Large Options Trading (NASDAQ:BNTX)
ETF DAILY NEWS· 17 hours agoBioNTech SE (NASDAQ:BNTX – Get Free Report) was the recipient of some unusual options trading on Monday. BMO Capital Markets cut their price objective on BioNTech ...
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 2 days agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
Investor's Business Daily· 2 days agoBioNTech stock seesawed before closing in the green on Monday following a disappointing...
Cracking The Code: Understanding Analyst Reviews For BioNTech - BioNTech (NASDAQ:BNTX)
Benzinga· 1 day agoLoading... Loading... Throughout the last three months, 12 analysts have evaluated BioNTech BNTX , offering a diverse set of opinions from bullish to bearish. The table below ...
AstraZeneca pulls its COVID vaccine from European market
WHIO-TV 7 Dayton· 58 minutes agoLONDON — (AP) — The pharma giant AstraZeneca has requested that the European authorization for its...
AstraZeneca withdraws its COVID-19 vaccine from global market
The Hill· 19 minutes agoThe shot, which was never authorized in the U.S., was widely used across the world in the early part...
BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
Barrons.com· 2 days agoFEATURE U.S.-listed shares of BioNTech were falling Monday after the German company that partnered...